Obesity Author: George A. Bray, MD
Editorial changes - 2009-11-18
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools

Quality Measures Quality Measures
Non-drug Therapy
  • Consider behavioral therapy with diet and exercise in overweight patients who need or want to lose weight.
  • Consider surgical treatment for very obese patients in whom other measures have failed.


Consider behavioral therapy with diet and exercise in overweight patients who need or want to lose weight. A

  • Recommend to overweight patients:
    • Behavioral therapy:
      • Recording food intake
      • Increasing physical activity
      • Being rewarded for success
    • Information about diets, emphasizing:
      • Amount and rate of weight loss, depending on degree of adherence to the diet
      • Importance of eating regularly
      • That at reduced energy intake under controlled conditions, diet composition is unimportant
      • That for some people, short-term very low-carbohydrate diets produce more weight loss than other diets but not always and not in the longer term
      • That low-fat diets produce weight loss but not more than other diets
      • That increased intake of high-fiber foods may enhance satiety
      • That higher protein diets may enhance satiety
      • That portion-controlled foods provide an easy way to count calories using commercial formulas, bars, or frozen meals
    • Exercise:
      • For 30 to 60 minutes 5 or more days a week by increasing walking or other comparable activities
    • Self-help groups
Background | Back to top


Consider surgical treatment for very obese patients in whom other measures have failed. A

Background | Back to top

FAQs
George A. Bray, MD, is a speaker for Eli Lilly, Amylin Corp., and Merck & Co., received grants from Merck & Co., and Takeda Pharmaceuticals; and has consulted for Sanofi-Aventis, Merck, and Amylin.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.